Daniel J. Dairaghi - Concepedia

Concepedia

Author

Daniel J. Dairaghi

ChemoCentryx (United States)

Also Known As

D Dairaghi, D J Dairaghi, D. Dairaghi, D. J. Dairaghi, D.J. Dairaghi, Daniel Dairaghi, Daniel J Dairaghi, Daniel J. Dairaghi

44

Publications

3.3K

Citations

26

H-Index

67

Concepts

All Affiliations

ChemoCentryx (United States)Stanford University Palo Alto Research Center Amgen (United States)Institut de Biologie Moléculaire et Cellulaire

DJ

About

Daniel J. Dairaghi is an author at ChemoCentryx (United States) specializing in medicine, immunology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	14	1.4K
2	Natural Sciences	3	3	238
3	Health Sciences	2	2	136
4	Social Sciences	1	1	103
5	Allergy	1	1	144

Daniel J. Dairaghi

×

28

Publications

3.3K

Citations

26

H-Index

	Year	Citations
CCR6, a CC Chemokine Receptor that Interacts with Macrophage Inflammatory Protein 3α and Is Highly Expressed in Human Dendritic Cells David R. Greaves, Wei Wang, Daniel J. Dairaghi, The Journal of Experimental Medicine	1997	359
C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN Hong Xiao, Daniel J. Dairaghi, Jay P. Powers, Journal of the American Society of Nephrology ImmunologyImmune RegulationImmunologic MechanismPharmacotherapyCrescentic Gn	2013	346
Cytomegalovirus encodes a potent α chemokine Mark E.T. Penfold, Daniel J. Dairaghi, Gregory Duke, Proceedings of the National Academy of Sciences	1999	333
Cutting Edge: Identification of a Novel Chemokine Receptor That Binds Dendritic Cell- and T Cell-Active Chemokines Including ELC, SLC, and TECK Jennifa Gosling, Daniel J. Dairaghi, Yu Wang, The Journal of Immunology Chemokine BiologyImmunologyImmunologic MechanismImmunotherapyBinds Dendritic Cell-	2000	201
Addition of a 29 Residue Carboxyl-terminal Tail Converts a Simple HMG Box-containing Protein into a Transcriptional Activator Daniel J. Dairaghi, Gerald S. Shadel, David A. Clayton Journal of Molecular Biology	1995	196
HHV8-encoded vMIP-I Selectively Engages Chemokine Receptor CCR8 Daniel J. Dairaghi, Rong A. Fan, Brian E. McMaster, Journal of Biological Chemistry	1999	190
Neuronal Fractalkine Expression in HIV-1 Encephalitis: Roles for Macrophage Recruitment and Neuroprotection in the Central Nervous System Ning Tong, Seth W. Perry, Qing Zhang, The Journal of Immunology	2000	186
Cytomegalovirus-encoded β chemokine promotes monocyte-associated viremia in the host Noah Saederup, Yu Lin, Daniel J. Dairaghi, Proceedings of the National Academy of Sciences	1999	163
Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease Matthew J. Walters, Yu Wang, Trageen Baumgart, Journal of Pharmacology and Experimental Therapeutics	2010	158
Characterization of Pharmacologic and Pharmacokinetic Properties of CCX168, a Potent and Selective Orally Administered Complement 5a Receptor Inhibitor, Based on Preclinical Evaluation and Randomized Phase 1 Clinical Study Pirow Bekker, Daniel J. Dairaghi, Lisa Seitz, PLoS ONE ImmunologyPotent C5ar AntagonistReceptor InhibitorPharmacotherapyImmunotherapy	2016	144

Page 1